(dollar amounts in thousands)	Estimated useful life in years		March 31, 2020			December 31, 2019
Trade name	Indefinite		$	5,871		$	5,871
Customer relationships		11		10,644			10,644
Non-compete agreements		5		157			157
				16,672			16,672
Less accumulated amortization				(9,393	)		(9,338	)
			$	7,279		$	7,334

The Company assesses potential impairment of its goodwill and intangible assets when there is evidence that events or circumstances have occurred that would indicate the recovery of an asset’s carrying value is unlikely. The Company also assesses potential impairment of its goodwill and intangible assets on an annual basis regardless of whether there is evidence of impairment. If indicators of impairment were to be present in intangible assets used in operations and future discounted cash flows were not expected to be sufficient to recover the asset’s carrying amount, an impairment loss would be charged to expense in the period identified. The amount of an impairment loss that would be recognized is the excess of the asset’s carrying value over its fair value. Factors the Company considers important, which may cause impairment include, among others, significant changes in the manner of use of the acquired asset, negative industry or economic trends, and significant underperformance relative to historical or projected operating results.

In response to the COVID-19 pandemic, the Company conducted a qualitative analysis of its goodwill and intangible assets and determined that no impairment triggering event had occurred in the fiscal quarter ended March 31, 2020.

Intangible assets with finite useful lives are amortized over their respective useful lives. Based on the carrying values at March 31, 2020 and assuming no subsequent impairment of the underlying assets, the amortization expense is expected to be $0.1 million for the remainder of fiscal year 2020, and $0.2 million in 2021 through 2026.